Skip to main content
logo
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
576.41
+16.88 (3.02%)
At close: Jul 28, 2026, 4:00 PM EDT
580.00
+3.59 (0.62%)
After-hours: Jul 28, 2026, 7:15 PM EDT

Thermo Fisher Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Revenue
11,99411,00512,21511,12210,85510,36411,39510,59810,54110,34510,88610,57410,68710,71011,45010,67710,97011,81810,7029,330
Revenue Growth
10.49%6.19%7.20%4.94%2.98%0.18%4.68%0.23%-1.37%-3.41%-4.93%-0.97%-2.58%-9.38%6.99%14.44%18.30%19.30%1.44%9.49%
Gross Profit
4,9434,4305,0114,5834,4094,2354,8224,3284,3474,2054,3934,3164,2514,1404,6064,3024,5995,4645,2544,651
Operating Income
2,0871,8632,2551,9411,8341,7162,0161,8381,8201,6631,8541,8641,5781,5631,8611,7102,0012,8212,5382,278
Net Income
1,7361,6511,9641,6161,6171,5071,8301,6301,5481,3281,6301,7151,3611,2891,5761,4951,6642,2151,6581,902
Earnings Per Share
4.684.435.214.274.283.984.784.254.043.464.204.423.513.324.013.794.225.614.174.79
EPS Growth
9.35%11.31%9.00%0.47%5.94%15.03%13.81%-3.85%15.10%4.22%4.74%16.62%-16.83%-40.82%-3.84%-20.88%-8.46%-4.59%-33.17%-1.03%

Revenue by Segment
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Life Sciences Solutions
2,8152,6362,9462,5882,4992,3412,6042,3872,3552,2852,4692,4332,4632,6123,0462,9623,2924,2314,1503,721
Analytical Instruments
1,8471,7162,2151,8931,7281,7182,1861,8081,7821,6872,0371,7541,7491,7231,8781,6211,6071,5181,7251,476
Specialty Diagnostics
1,2051,1421,2201,1741,1341,1481,1571,1291,1171,1091,1051,0831,1091,1081,1151,0651,1011,4821,4471,362
Laboratory Products and Biopharma Services
6,6936,0366,3795,9705,9955,6405,9365,7405,7585,7235,7195,7285,8315,7635,9475,5855,5375,4424,1953,487
Revenue (Total)
11,99411,00512,21511,12210,85510,36411,39510,59810,54110,34510,88610,57410,68710,71011,45010,67710,97011,81810,7029,330

Cash & Debt
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Cash & Investments
4,0643,25610,1053,5466,3905,9475,5706,6458,8237,2508,0806,1513,1333,4828,5242,9191,8882,7524,47712,027
Total Debt
42,54943,16139,38535,68035,22934,18931,27535,31335,40535,60834,91735,28434,00835,25734,48829,16030,26033,25534,87021,707
Net Cash (Debt)
-38,485-39,905-29,280-32,134-28,839-28,242-25,705-28,668-26,582-28,358-26,837-29,133-30,875-31,775-25,964-26,241-28,372-30,503-30,393-9,680
Net Cash Growth
--------------------
Net Cash Per Share
-103.73-106.98-77.67-85.01-76.29-74.52-67.11-74.66-69.40-73.85-69.17-75.09-79.57-81.89-66.07-66.43-72.01-77.22-76.36-24.38

Cash Flow & CapEx
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Operating Cash Flow
2,1251,1923,4572,2391,3997233,2902,1661,9601,2513,7232,4141,5407293,4871,9371,5282,2022,4572,650
Capital Expenditures
-450-376-465-404-294-362-480-272-301-347-405-332-284-458-550-547-506-640-831-524
Free Cash Flow
1,6758162,9921,8351,1053612,8101,8941,6599043,3182,0821,2562712,9371,3901,0221,5621,6262,126
Free Cash Flow Growth
51.58%126.04%6.48%-3.12%-33.39%-60.07%-15.31%-9.03%32.09%233.58%12.97%49.78%22.90%-82.65%80.63%-34.62%-39.42%15.70%-40.94%-9.22%

Margins
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Gross Margin
41.21%40.25%41.02%41.21%40.62%40.86%42.32%40.84%41.24%40.65%40.35%40.82%39.78%38.66%40.23%40.29%41.92%46.23%49.09%49.85%
Operating Margin
17.40%16.93%18.46%17.45%16.90%16.56%17.69%17.34%17.27%16.08%17.03%17.63%14.77%14.59%16.25%16.02%18.24%23.87%23.72%24.42%
Pretax Margin
16.04%15.76%17.63%16.42%15.74%15.63%17.03%16.44%16.74%15.36%15.98%16.69%13.38%12.73%15.52%14.99%17.47%21.49%17.40%23.33%
Profit Margin
14.65%15.12%16.37%14.56%14.90%14.71%15.72%15.50%15.53%12.64%14.76%16.19%12.89%12.30%14.01%14.70%15.67%18.95%15.50%20.43%
FCF Margin
13.97%7.41%24.49%16.50%10.18%3.48%24.66%17.87%15.74%8.74%30.48%19.69%11.75%2.53%25.65%13.02%9.32%13.22%15.19%22.79%

Dividends
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
Dividend Per Share
-0.4700.4300.4300.4300.4300.3900.3900.3900.3900.3500.3500.3500.3500.3000.3000.3000.3000.2600.260
Dividend Per Share Growth
-9.30%10.26%10.26%10.26%10.26%11.43%11.43%11.43%11.43%16.67%16.67%16.67%16.67%15.38%15.38%15.38%15.38%18.18%18.18%
Dividend Yield
0.09%0.09%0.07%0.09%0.10%0.08%0.07%0.06%0.07%0.06%0.07%0.07%0.07%0.05%0.05%0.06%0.05%0.04%0.04%0.05%

Valuation
Chart
Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21
PE Ratio
27.6026.0232.6626.8223.6129.3331.4738.5234.3137.2834.3633.1735.6637.5731.2428.5129.1830.8834.2926.61
Forward PE
20.2219.2224.0519.8117.9221.4122.8727.3124.8226.9324.6521.3921.2524.2725.0022.6625.0226.2932.5529.37
P/FCF Ratio
26.0526.0734.6428.5424.9928.0827.2630.2326.5329.3529.6329.8834.4039.5631.0035.5233.9033.1238.7528.51
PS Ratio
4.113.894.893.993.574.404.625.554.995.224.794.504.635.074.774.505.025.646.715.78